Published Date:2021-12-17 Original Link:https://www.onenessbio.com/en/news_detail130_1.htm No 1 Date of announcement 2021/12/17 Time of announcement 17:37:36 Subject The Singapore Health Science Authority has accepted the NDA application of the diabetic foot ulcer new drug, Fespixon To which item it meets paragraph 53 Date of events 2021/12/17 Statement          1.Product:ON101 Diabetic foot ulcer new drug 2.Mass...Read More